Scalper1 News
Embattled specialty-drug giant Valeant Pharmaceuticals (VRX) said Monday that it’s appointing an ad hoc committee to review its relationship with Philidor, a specialty pharmacy that has become the center of a barrage of allegations in recent weeks. The once-leading stock continued to struggle, falling as much as 6.4% in early trading in the stock market today. In midday trading, Valeant stock was down nearly 2%, near 114. Shares touched an Scalper1 News
Scalper1 News